Regent Peak Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,820
Closed -$402K 169
2024
Q1
$402K Buy
5,820
+1
+0% +$63 0.1% 96
2023
Q4
$430K Buy
5,819
+10
+0.2% +$655 0.12% 87
2023
Q3
$396K Hold
5,809
0.12% 89
2023
Q2
$545K Sell
5,809
-4,636
-44% -$362K 0.16% 75
2023
Q1
$708K Sell
10,445
-1,159
-10% -$74.5K 0.22% 66
2022
Q4
$575K Sell
11,604
-578
-5% -$23.6K 0.19% 77
2022
Q3
$395K Hold
12,182
0.14% 92
2022
Q2
$479K Buy
+12,182
New +$651K 0.16% 88
2021
Q1
Sell
-36
Closed -$5K 416
2020
Q4
$5K Buy
+36
New +$4.35K ﹤0.01% 666

Other funds holding EXAS

Regent Peak Wealth Advisors's EXAS Position: Q2 2024 in Review

Regent Peak Wealth Advisors sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 5,820 shares — an estimated $402K sold.

Regent Peak Wealth Advisors first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $708K in Q1 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Regent Peak Wealth Advisors reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Regent Peak Wealth Advisors sold 5,820 Exact Sciences shares in Q2 2024, an estimated $402K.
  • Regent Peak Wealth Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
  • Regent Peak Wealth Advisors's Exact Sciences position peaked at $708K in Q1 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Regent Peak Wealth Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.